相似文献
1
Is buprenorphine-naloxone ready for prime time in the treatment of opioid addiction in managed care?
J Manag Care Pharm. 2008 Mar;14(2):195-7. doi: 10.18553/jmcp.2008.14.2.195.
2
In brief: Buprenorphine/naloxone (Zubsolv) for opioid dependence.
Med Lett Drugs Ther. 2013 Oct 14;55(1427):83.
3
Tramadol dependence: treatment with buprenorphine/naloxone.
Am J Addict. 2007 Jan-Feb;16(1):67-8. doi: 10.1080/10550490601080118.
4
Opioid drug utilization and cost outcomes associated with the use of buprenorphine-naloxone in patients with a history of prescription opioid use.
J Manag Care Pharm. 2008 Mar;14(2):186-94. doi: 10.18553/jmcp.2008.14.2.186.
5
Loperamide Addiction: Atypical Opioid Use Disorder Treated With Buprenorphine/Naloxone.
Prim Care Companion CNS Disord. 2019 Jul 3;21(4):19l02446. doi: 10.4088/PCC.19l02446.
6
Initiating Opioid Agonist Treatment for Opioid Use Disorder in the Inpatient Setting: A Teachable Moment.
JAMA Intern Med. 2019 Mar 1;179(3):427-428. doi: 10.1001/jamainternmed.2018.6749.
7
Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines.
J Opioid Manag. 2013 Jul-Aug;9(4):237.
8
Use and misuse of opioid replacement therapies: a Queensland study.
Subst Use Misuse. 2012 Jan;47(1):78-85. doi: 10.3109/10826084.2011.629017.
9
Food and Drug Administration approval of buprenorphine-naloxone for office treatment of addiction.
Ann Intern Med. 2003 Feb 18;138(4):360. doi: 10.7326/0003-4819-138-4-200302180-00027.
10
Buprenorphine maintenance: a new treatment for opioid dependence.
Cleve Clin J Med. 2007 Jul;74(7):514-20. doi: 10.3949/ccjm.74.7.514.
Zotero 插件